Stock Market Close, June 19, 2026: IT Rout Overshadows Oil Even as Defence and Pharma Try to Cushion Market Fall

Mumbai, June 19: Friday saw a steep selloff in IT shares dragging benchmark indices lower. Heavyweight Reliance Industries which started its annual general meeting during market hours worsened the sentiment. Financials added to the woes even as defence and pharma came to the rescue of the markets.  

Biggest Laggard 

Nifty IT index tumbled to a three-year low as Accenture scared stocks. Source: NSE 

The Nifty IT index emerged as the biggest laggard, tumbling 3.7% to a three-year low after global IT bellwether Accenture issued weaker-than-expected revenue guidance and warned of a $400 million hit to its Middle East business from the Iran conflict.  

The cautious outlook raised concerns about discretionary technology spending and prompted investors to cut exposure to Indian software exporters. All major IT stocks ended lower, with Infosys, TCS, HCLTech, Wipro and Tech Mahindra among the key drags on the benchmarks.  

Financials Weigh 

Nifty Financial Services index fell 0.6%, adding to market woes. Source: NSE  

Financial stocks also weighed on sentiment. HDFC Bank declined after the Reserve Bank of India approved a three-month extension for interim Chairman Keki Mistry, adding to uncertainty around the lender’s leadership transition. 

Oil & Gas Declines 

The Nifty Oil & Gas index declined as heavyweight Reliance Industries fell 1.4%, with investors booking profits after a recent run-up driven by expectations surrounding its annual general meeting. The stock came under pressure despite the company approving plans to raise funds through the proposed listing of Jio Platforms. Reliance Industries also unveiled ambitious artificial intelligence and satellite connectivity plans at its annual general meeting. 

Consumer Durables Decline, Defence Advances 

Consumer-facing sector declined. 

The Nifty Consumer Durables index declined as Bata India led the fall on profit booking after soaring yesterday after the footwear maker said ex-Nike retail head Sanjay Rao would be taking over as CEO.  

Several defence counters remained in focus after the sector’s recent rally, supported by record defence production and export figures reported for the last financial year. Investors continued to favour companies expected to benefit from India’s push for self-reliance in military manufacturing and rising procurement from domestic suppliers. Paras Defence and Space Technologies rose for the third session on great expectations.  

Pharma Rises 

Nifty Pharma index rose 0.7% as investors preferred defensives amid IT rout and some counters rose on stock specific news. Aurobindo Pharma jumped after getting the US Federal Trade Commission (FTC) green light for the acquisition of Lannett business.  

Alembic Pharmaceuticals rose after tentative approval from the U.S. Food and Drug Administration (USFDA) for its Binimetinib Tablets, 45 mg, strengthening the company’s oncology portfolio and expanding its pipeline of cancer-treatment products targeted at the U.S. market. 

Broader Market Holds Up 

Nifty Smallcap 100 rose 0.4%, outperforming headline indices. Source: NSE  

Despite weakness in large-cap technology and financial stocks, the broader market showed resilience. 

Mid-cap and small-cap shares outperformed the headline indices, extending their strong weekly performance. Market breadth remained positive, with advancing stocks outnumbering decliners on the NSE, indicating that selling pressure was concentrated in a handful of heavyweight sectors rather than spread across the market.  

Analysts expect markets to enter a phase of consolidation after the recent rally, with support from lower crude oil prices likely offset by concerns over global technology demand and the prospect of tighter U.S. monetary policy. However, continued strength in domestic-facing sectors such as consumption, defence and industrials suggests investors remain constructive on India’s broader growth outlook.  

Source

NSE